Ensign Peak Advisors’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,230
| Closed | -$63K | – | 1857 |
|
|
2022
Q3 | $63K | Buy |
7,230
+4,670
| +182% | +$40.7K | ﹤0.01% | 2173 |
|
|
2022
Q2 | $19K | Sell |
2,560
-25,793
| -91% | -$191K | ﹤0.01% | 2128 |
|
|
2022
Q1 | $688K | Hold |
28,353
| – | – | ﹤0.01% | 1412 |
|
|
2021
Q4 | $913K | Buy |
28,353
+2,560
| +10% | +$82.4K | ﹤0.01% | 1346 |
|
|
2021
Q3 | $1.15M | Sell |
25,793
-14,207
| -36% | -$635K | ﹤0.01% | 1379 |
|
|
2021
Q2 | $1.51M | Hold |
40,000
| – | – | ﹤0.01% | 1265 |
|
|
2021
Q1 | $1.48M | Hold |
40,000
| – | – | ﹤0.01% | 1256 |
|
|
2020
Q4 | $1.33M | Buy |
+40,000
| New | +$1.33M | ﹤0.01% | 1275 |
|